Cargando…
Delay in the Provision of Antiretroviral Therapy to HIV-infected TB Patients in Nigeria
BACKGROUND: Nigeria has a high burden of HIV and tuberculosis (TB). To reduce TB-associated morbidity and mortality, the World Health Organization recommends that HIV-positive TB patients receive antiretroviral therapy (ART) within eight weeks of TB treatment initiation, or within two weeks if profo...
Autores principales: | Odume, B., Pathmanathan, I., Pals, S., Dokubo, K., Onotu, D., Obinna, O., Anand, D., Okuma, J, Okpokoro, E., Dutt, S., Ekong, E., Chukwurah, N., Dakum, P., Tomlinson, H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016393/ https://www.ncbi.nlm.nih.gov/pubmed/29951573 http://dx.doi.org/10.13189/ujph.2017.050507 |
Ejemplares similares
-
Provision of Antiretroviral Therapy for HIV-Positive TB Patients — 19 Countries, Sub-Saharan Africa, 2009–2013
por: Dokubo, E. Kainne, et al.
Publicado: (2014) -
High uptake of antiretroviral therapy among HIV-positive TB patients receiving co-located services in Swaziland
por: Pathmanathan, Ishani, et al.
Publicado: (2018) -
Incidence and predictors of tuberculosis among HIV-infected adults after initiation of antiretroviral therapy in Nigeria, 2004-2012
por: Pathmanathan, Ishani, et al.
Publicado: (2017) -
Epidemiologic and viral predictors of antiretroviral drug resistance among persons living with HIV in a large treatment program in Nigeria
por: Ekong, Ernest, et al.
Publicado: (2020) -
Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria
por: Bada, Florence O., et al.
Publicado: (2020)